Can You Take Latuda When You Have Seizures?
Latuda (lurasidone) can be used cautiously in patients with a history of seizures, but it requires careful risk-benefit assessment and close monitoring. The FDA label explicitly states that lurasidone should be used cautiously in patients with a history of seizures or conditions that lower the seizure threshold 1.
Key Considerations from FDA Labeling
The official FDA prescribing information for Latuda provides clear guidance 1:
- Use with caution in patients with a history of seizures
- Use with caution in patients with conditions that lower the seizure threshold (e.g., Alzheimer's dementia)
- Seizure threshold-lowering conditions are more prevalent in patients ≥65 years
Clinical Trial Data on Seizure Risk
In controlled schizophrenia trials, seizures/convulsions occurred in only 0.1% (2/1508) of Latuda-treated patients versus 0.1% (1/708) of placebo patients 1.
In bipolar depression trials (both monotherapy and adjunctive therapy), no patients experienced seizures/convulsions 1.
Real-World Seizure Risk Profile
Recent pharmacovigilance data from the FDA Adverse Event Reporting System provides important context 2:
- Lurasidone demonstrated comparatively lower seizure-related signals compared to other atypical antipsychotics
- Among eight commonly used atypical antipsychotics analyzed, lurasidone (along with risperidone and paliperidone) showed the lowest association with seizure reports
- Higher-risk agents included ziprasidone, quetiapine, clozapine, olanzapine, and aripiprazole 2
Clinical Decision Algorithm
For Uncontrolled Seizures:
- Optimize seizure control first before initiating Latuda
- Ensure patient is on appropriate antiepileptic medication
- Consider consultation with neurology
For Controlled Seizures (Seizure-Free on Antiepileptics):
- Latuda can be considered if psychiatric indication is strong
- Start at lower dose (20 mg/day) rather than standard starting doses
- Titrate slowly while monitoring for seizure activity
- Maintain therapeutic antiepileptic drug levels
- Monitor for drug interactions (Latuda is metabolized by CYP3A4)
For History of Seizures (Remote, No Current Antiepileptics):
- Assess seizure risk factors: time since last seizure, underlying cause, EEG findings if available
- If remote history (>2 years seizure-free without medications), Latuda can be used with standard monitoring
- Educate patient/family about seizure warning signs
- Consider lower starting dose in high-risk patients
Important Drug Interactions
Critical contraindication: Do not use Latuda with strong CYP3A4 inducers like phenytoin or carbamazepine (common antiepileptic drugs), as these will significantly reduce lurasidone levels and render it ineffective 1.
Compatible antiepileptic options include:
- Valproic acid (actually studied as adjunctive therapy with Latuda in bipolar depression) 1
- Levetiracetam
- Lamotrigine
- Topiramate
Special Populations
Elderly patients: Exercise additional caution as conditions lowering seizure threshold are more prevalent 1. Consider starting at 20 mg/day.
Pediatric patients: Case reports document successful use in adolescents with epilepsy comorbidity 3, though this requires careful monitoring.
Monitoring Requirements
- Baseline seizure history documentation
- Regular assessment for new-onset seizure activity
- Monitor for somnolence (reported in 14-17% of patients), which could mask seizure symptoms 1
- Avoid factors that lower seizure threshold: sleep deprivation, alcohol, excessive heat/dehydration 1
Bottom Line
Latuda is among the safer atypical antipsychotics regarding seizure risk 2, making it a reasonable option for patients with controlled seizures or remote seizure history. The key is ensuring seizures are well-controlled, avoiding contraindicated antiepileptic drugs (phenytoin, carbamazepine), starting at lower doses, and maintaining vigilant monitoring. For patients with uncontrolled seizures, stabilize the seizure disorder first before initiating any antipsychotic therapy.